S. Bi

发表

The involvement of "tumor suppressor" p53 in normal and chronic myelogenous leukemia hemopoiesis.

F. Lanza, S. Bi, J. Goldman, 1994, Cancer research.

Modulation of cell kinetics and cell cycle status by treating CD34+ chronic myeloid leukaemia cells with p53 antisense phosphorothioate oligonucleotides

F. Lanza, S. Moretti, S. Bi, 1995, British journal of haematology.

Role of p53 in leukemogenesis of chronic myeloid leukemia

F. Lanza, S. Bi, 1995, Stem cells.

Cytokine gene activity in AML cells in vivo in patients.

P. Venugopal, H. Preisler, S. Bi, 1998, Leukemia research.

The Premyelodysplastic State and the Secondary Hematologic Disorders

H. Preisler, S. Bi, Jie Yang, 1998 .

The abnormal p53 proteins expressed in CML cell lines are non-functional.

F. Lanza, S. Bi, J. Goldman, 1993, Leukemia.

p53 in chronic myeloid leukemia cell lines.

S. Bi, J. Goldman, A. Chase, 1992, Leukemia.

Marrow cytokine transcripts and the secondary hematologic disorders.

H. Preisler, S. Bi, A. Raza, 1999, Leukemia and Lymphoma.

Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.

F Lanza, F. Lanza, S. Bi, 1993, Leukemia.

Control of Leukemia Proliferation in vivo in Patients: In vivo Cytokine Production

P. Venugopal, H. Preisler, S. Bi, 1998 .

Acute lymphoblastic leukemia presenting with an acute fibrinous and organizing pneumonia

Do, S. Bi, R. Servi, 2007 .

Retroviral transduction of Philadelphia-positive chronic myeloid leukemia cells with a human mutant p53 cDNA and its effect on in vitro proliferation.

S. Bi, J. Goldman, N. Lemoine, 1994, Experimental hematology.

Cytokines, molecular biological abnormalities, and acute myelogenous leukemia.

P. Venugopal, H. Preisler, S. Bi, 1997, Leukemia research.